1-1 of 1
Wenbin Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma

Jia Liu, Zilu Zhang, Wenbin Xu, Mingyuan Jia, Xinyi Zeng, Chengyu Wu, Ze Fu, Xiaoguang Xu, Chenjing Ye, Chao Wu, Hanzhang Xu, Hu Lei, Ying-Li Wu, Yan Hua
Journal: Blood Advances
Blood Adv bloodadvances.2025015815.
https://doi.org/10.1182/bloodadvances.2025015815
Published: 2025
Includes: Supplemental data